Margot Lindsay

Counsel, London

Biography

Overview

Margot is counsel in the London Corporate/M&A practice. She advises listed companies, private companies, financial sponsors and international corporates on international and domestic public and private M&A, joint ventures, reorganisations and general corporate advisory matters.

Margot has broad experience across a range of industries, with a particular focus on healthcare, consumer products and infrastructure.

Prior to joining White & Case, Margot worked for one of the UK’s magic circle law firms for 8 years and also worked for a top tier law firm in New Zealand.

Bars and Courts
England and Wales
Education
LLB
University of Otago

New Zealand

BCom
University of Otago

New Zealand

Languages
English

Experience

MOL Group on its announced US$1.57 billion deal with Chevron to acquire a 9.57 percent stake in the Azeri-Chirag-Gunashli (ACG) oil field in the Caspian Sea off Azerbaijan and an effective 8.90 percent interest in the Baku-Tbilisi-Ceyhan (BTC) pipeline.

Avon Rubber plc on its announced agreement to acquire 3M's ballistic-protection business in the US. Avon is a UK-listed innovative technology group, specialising in chemical, biological, radiological and nuclear (CBRN) and respiratory protection systems.

Allianz Capital Partners on its co-investment in GasNet, the Czech Republic's largest gas distribution network business, as part of a consortium of investors led by Macquarie Infrastructure and Real Assets.

J Sainsbury plc on its proposed £15 billion merger with Asda.*

Reckitt Benckiser Group plc on the US$17.9 billion acquisition of Mead Johnson Nutrition Company.*

UBM plc on its takeover by Informa plc for £3.8 billion.*

Macquarie on the acquisition of a 50 percent interest in the Race Bank Offshore Wind Farm from Ørsted for £1.6 billion.*

Anglo American on the US$1.7 billion sale of its niobium and phosphates divisions to China Molybdenum.*

Novartis on its asset swap with GSK, where Novartis sold its vaccines business to GSK for US$7.1 billion, Novartis acquired GSK's oncology business for US$16 billion and the parties entered into a joint venture in respect of the parties' consumer health businesses.*

Takeda Pharmaceuticals on the US$578 million sale of its core respiratory product portfolio to AstraZeneca.*

UniCredit Group on its aborted £5.45 billion global asset management joint venture with Banco Santander, Warburg Pincus and General Atlantic.*

*Matters worked on prior to joining White & Case.